Federal appeals court hears CRISPR patent dispute – Science Magazine
Science Magazine |
Federal appeals court hears CRISPR patent dispute
Science Magazine That mind-bending question was the centerpiece of a case heard today by the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., over the lucrative patent portfolio surrounding the revolutionary genome editor commonly known as CRISPR … UC vs. Harvard: Round 2 in CRISPR fightThe Mercury News Billions of dollars are at stake, so the fight over who owns CRISPR is back in courtMIT Technology Review It’s ‘going to be tough’: UC Berkeley struggles to find sympathetic court in CRISPR patent appealSTAT Seeking Alpha –Reuters all 7 news articles » |
Drug Discovery & Development |
T-Cell Biomarker Predicts Which CLL Patients Will Respond to CAR …
Drug Discovery & Development Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don’t respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients’ immune systems are … Healthy T cells have a fighting chance for cell therapy | Penn TodayPenn: Office of University Communications |
|
Revolutionary one-day stem cell treatment could save lives of hundreds of thousands suffering heart failure
Mirror.co.uk The very thought of being a guinea pig would be understandably terrifying but, figuring she had nothing to lose, Denise applied for the stem cell treatment at St Bartholomew’s Hospital, London. Just months after the pioneering treatment, using adult … |
Maryland Daily Record |
University of Maryland opens lab for immunotherapy
Maryland Daily Record The University of Maryland School of Medicine Monday opened a lab the university hopes will be home to the creation of the next generation of cancer cures. The Fannie Angelos Cellular Therapeutics Lab will be used for immunotherapy, engineering cells … University of Maryland opens cancer lab in Baltimore named after Peter Angelos’ sisterBaltimore Sun |